Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Mar 2007

Cid A R, Casaña P, Cabrera N, Haya S, Cortina V, Aznar J A

Abstract excerpt

Certain mutations in mild haemophilia A have been associated with a greater risk of inhibitor development, especially when associated with intense treatment. We present a patient with both mild haemophilia A and Arg531Cys mutation, which developed lowtitre inhibitors and was not seen to be relate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Antibody Formation
Share to Blood Coagulation Factor Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Laboratory Techniques

Share to Factor VIII

Share to Hemophilia A

Share to Pedigree

Share to Reference Standards

Source

Identifiers

PMID: 17286776
DOI: 10.1111/j.1365-2516.2006.01422.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17286776-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation.PMID 17286776Read ↗

Inhibitors to Factor VIII in a Family with Mild Hemophilia: Molecular Characterization and Response to Factor VIII and DesmopressinSemantic proximity Read ↗

One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.Semantic proximity Read ↗

Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay.Semantic proximity Read ↗

Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.Semantic proximity Read ↗

Development of exogenous FVIII-specific inhibitor in a mild haemophilia patient with Glu272Lys mutation.Semantic proximity Read ↗

Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.Semantic proximity Read ↗

Tyr346-->Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype - is this mild haemophilia A?Semantic proximity Read ↗

Inhibitors in mild/moderate haemophilia A: an update.Semantic proximity Read ↗

Normalization of factor VIII levels in a patient with mild haemophilia A during a 35-year period.Semantic proximity Read ↗

Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype.Semantic proximity Read ↗

One-stage vs. chromogenic assays in haemophilia A.Semantic proximity Read ↗

MUTATIONS IN A SUBGROUP OF PATIENTS WITH MILD HAEMOPHILIA A AND A FAMILIAL DISCREPANCY BETWEEN THE ONE‐STAGE AND TWO‐STAGE FACTOR VIII:C METHODSSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.